Stabilization of HIPK2 by escape from proteasomal degradation mediated by the E3 ubiquitin ligase Siah1

Cancer Letters

Volumn 279, Issue 2, 2009, Pages 177-184

  Kim, Se Yong ^a   Choi, Dong Wook ^a   Kim, Eun A ^a   Choi, Cheol Yong ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

HIPK2; Poly ubiquitination; Proteasomal degradation; Siah1

Indexed keywords

DNA; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; LATENT MEMBRANE PROTEIN 1; MIXED LINEAGE KINASE 3; SEVEN IN ABSENTIA HOMOLOG 1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DNA DAMAGE; EMBRYO; ENZYME DEGRADATION; ENZYME STABILITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TARGETING; STIMULUS; UBIQUITINATION; YEAST;

ANIMALS; CARRIER PROTEINS; CELL LINE; CERCOPITHECUS AETHIOPS; HUMANS; MAP KINASE KINASE KINASES; MUTATION; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; VIRAL MATRIX PROTEINS;

EID: 66749097258     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.01.036     Document Type: Article

References (27)

1. Kim Y.H., Choi C.Y., Lee S.J., Conti M.A., and Kim Y. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J. Biol. Chem. 273 (1998) 25875-25879
2. Arai S., Matsushita A., Du K., Yagi K., Okazaki Y., and Kurokawa R. Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9. FEBS Lett. 581 (2007) 5649-5657
3. Rinaldo C., Prodosmo A., Siepi F., and Soddu S. HIPK2: a multitalented partner for transcription factors in DNA damage response and development. Biochem. Cell Biol. 85 (2007) 411-418
4. Calzado M.A., Renner F., Roscic A., and Schmitz M.L. HIPK2: a versatile switchboard regulating the transcription machinery and cell death. Cell Cycle 6 (2007) 139-143
5. Sombroek D., and Hofmann T.G. How cells switch HIPK2 on and off. Cell Death Differ. 31 (2008) 1-8
6. D'Orazi G., Cecchinelli B., Bruno T., Manni I., Higashimoto Y., Saito S., Gostissa M., Coen S., Marchetti A., Del Sal G., Piaggio G., Fanciulli M., Appella E., and Soddu S. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol. 4 (2002) 11-19
7. Di Stefano V., Rinaldo C., Sacchi A., Soddu S., and D'Orazi G. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Exp. Cell Res. 293 (2004) 311-320
8. Zhang Q., Yoshimatsu Y., Hildebrand J., Frisch S.M., and Goodman R.H. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 115 (2003) 177-186
9. Wei G., Ku S., Ma G.K., Saito S., Tang A.A., Zhang J., Mao J.H., Appella E., Balmain A., and Huang E.J. HIPK2 represses β-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc. Natl. Acad. Sci. USA 104 (2007) 13040-13045
10. Deshmukh H., Yeh T.H., Yu J., Sharma M.K., Perry A., Leonard J.R., Watson M.A., Gutmann D.H., and Nagarajan R. High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas. Oncogene 27 (2008) 4745-4751
11. Al-Beiti M.A., and Lu X. Expression of HIPK2 in cervical cancer: correlation with clinicopathology and prognosis. Aust. N. Z. J. Obstet. Gynaecol. 48 (2008) 329-336
12. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat. Rev. Mol. Cell Biol. 6 (2005) 79-87
13. Choi D.W., Seo Y.M., Kim E.A., Sung K.S., Ahn J.W., Park S.J., Lee S.R., and Choi C.Y. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1. J. Biol. Chem. 283 (2008) 4682-4689
14. Sung K.S., Go Y.Y., Ahn J.H., Kim Y.H., Kim Y., and Choi C.Y. Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation. FEBS Lett. 579 (2005) 3001-3008
15. Kim E.A., Noh Y.T., Ryu M.J., Kim H.T., Lee S.E., Kim C.H., Lee C., Kim Y.H., and Choi C.Y. Phosphorylation and transactivation of Pax6 by homeodomain-interacting protein kinase 2. J. Biol. Chem. 281 (2006) 7489-7497
16. Boehm J., He Y., Greiner A., Staudt L., and Wirth T. Regulation of BOB.1/OBF.1 stability by SIAH. EMBO J. 20 (2001) 4153-4162
17. Zhang J., Guenther M.G., Carthew R.W., and Lazar M.A. Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes Dev. 12 (1998) 1775-1780
18. Fanelli M., Fantozzi A., De Luca P., Caprodossi S., Matsuzawa S., Lazar M.A., Pelicci P.G., and Minucci S. The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome. J. Biol. Chem. 279 (2004) 5374-5379
19. Susini L., Passer B.J., Amzallag-Elbaz N., Juven-Gershon T., Prieur S., Privat N., Tuynder M., Gendron M.C., Israel A., Amson R., Oren M., and Telerman A. Siah-1 binds and regulates the function of Numb. Proc. Natl. Acad. Sci. USA 98 (2001) 15067-15072
20. Winter M., Sombroek D., Dauth I., Moehlenbrink J., Scheuermann K., Crone J., and Hofmann T.G. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat. Cell Biol. 10 (2008) 812-824
21. Xu Z., Sproul A., Wang W., Kukekov N., and Greene L.A. Siah1 interacts with the scaffold protein POSH to promote JNK activation and apoptosis. J. Biol. Chem. 281 (2006) 303-312
22. Kim K.Y., Kim B.C., Xu Z., and Kim S.J. Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-β-induced apoptosis in hepatoma cells. J. Biol. Chem. 279 (2004) 29478-29484
23. Jang K.L., Shackelford J., Seo S.Y., and Pagano J.S. Up-regulation of β-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. Proc. Natl. Acad. Sci. USA 102 (2005) 18431-18436
24. Kondo S., Seo S.Y., Yoshizaki T., Wakisaka N., Furukawa M., Joab I., Jang K.L., and Pagano J.S. EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1α through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. Cancer Res. 66 (2006) 9870-9877
25. Eliopoulos A.G., and Young L.S. LMP1 structure and signal transduction. Semin. Cancer Biol. 11 (2001) 435-444
26. Calzado M.A., de la Vega L., Moller A., Bowtell D.D., and Schmitz M.L. An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. Nat. Cell Biol. 11 (2009) 85-91
27. Shima Y., Shima T., Chiba T., Irimura T., Pandolfi P.P., and Kitabayashi I. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol. Cell. Biol. 28 (2008) 7126-7138